Zifo Technologies has launched its AI-Powered Antibody Engineering application, a cloud-native solution on the Snowflake Data Cloud designed to enhance antibody development for biopharma companies and research institutions. This innovative platform streamlines therapeutic antibody design, potentially reducing drug discovery timelines and costs without transferring sensitive data outside Snowflake.
The application incorporates advanced AI in an intuitive, no-code interface, facilitating the entire process from generating novel antibody sequences to predicting 3D structures. It leverages powerful protein models like ProtGPT2 and ESM2, enabling scientists to fine-tune these models using proprietary datasets securely.
Zifo’s partnership with Snowflake enhances compliance and security while democratizing access to complex AI tools, making it easier for R&D teams, CDMOs, and academic institutions to innovate. Furthermore, the app supports clinical and preclinical development by validating AI-generated antibodies, thus accelerating lead selection.
For more details, visit Zifo at zifornd.com.
Source link
